|
Volumn 353, Issue 9166, 1999, Pages 1793-1796
|
CAPPP trial (multiple letters) [1]
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
INSULIN;
RENIN;
ANTIHYPERTENSIVE AGENT;
BLOOD PRESSURE REGULATION;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIASTOLIC BLOOD PRESSURE;
DRUG COST;
DRUG MECHANISM;
DRUG SAFETY;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART PROTECTION;
HEMODYNAMICS;
HUMAN;
HYPERTENSION;
INSULIN SENSITIVITY;
LETTER;
MAJOR CLINICAL STUDY;
MORBIDITY;
PRIORITY JOURNAL;
TRANSIENT ISCHEMIC ATTACK;
CEREBROVASCULAR DISEASE;
MIDDLE AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CAPTOPRIL;
CEREBROVASCULAR DISORDERS;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
|
EID: 0033594727
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(99)00091-4 Document Type: Letter |
Times cited : (11)
|
References (4)
|